Donna C. Wortman

Array ( [id] => 6289244 [patent_doc_number] => 20020054884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate' [patent_app_type] => new [patent_app_number] => 09/951657 [patent_app_country] => US [patent_app_date] => 2001-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2483 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20020054884.pdf [firstpage_image] =>[orig_patent_app_number] => 09951657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016099 [patent_doc_number] => 20020102726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Immortalized human keratinocyte cell line' [patent_app_type] => new [patent_app_number] => 09/945136 [patent_app_country] => US [patent_app_date] => 2001-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13286 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102726.pdf [firstpage_image] =>[orig_patent_app_number] => 09945136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1352923 [patent_doc_number] => 06576417 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-10 [patent_title] => 'Synthetic antigens for the detection of antibodies to hepatitis C virus' [patent_app_type] => B2 [patent_app_number] => 09/941611 [patent_app_country] => US [patent_app_date] => 2001-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 11721 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576417.pdf [firstpage_image] =>[orig_patent_app_number] => 09941611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6129957 [patent_doc_number] => 20020076834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Immunological method for detecting antibodies directed against tissue transglutaminase (tTG), use of tTG in diagnosis and therapy control, and an oral pharmaceutical agent containing tTG' [patent_app_type] => new [patent_app_number] => 09/925076 [patent_app_country] => US [patent_app_date] => 2001-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6927 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20020076834.pdf [firstpage_image] =>[orig_patent_app_number] => 09925076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869829 [patent_doc_number] => 20030082518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease' [patent_app_type] => new [patent_app_number] => 09/919901 [patent_app_country] => US [patent_app_date] => 2001-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11425 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082518.pdf [firstpage_image] =>[orig_patent_app_number] => 09919901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1334900 [patent_doc_number] => 06593082 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'In vitro activity assay for human hepatitis B virus (HBV) DNA polymerase, and its use for screening for inhibitors of HBV DNA polymerase' [patent_app_type] => B1 [patent_app_number] => 09/674465 [patent_app_country] => US [patent_app_date] => 2001-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 4644 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593082.pdf [firstpage_image] =>[orig_patent_app_number] => 09674465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6408198 [patent_doc_number] => 20020037868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Method for detecting hepatitis C' [patent_app_type] => new [patent_app_number] => 09/880945 [patent_app_country] => US [patent_app_date] => 2001-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 14659 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037868.pdf [firstpage_image] =>[orig_patent_app_number] => 09880945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6157437 [patent_doc_number] => 20020146685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Immunoassays for anti-HCV antibodies' [patent_app_type] => new [patent_app_number] => 09/881654 [patent_app_country] => US [patent_app_date] => 2001-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 21961 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146685.pdf [firstpage_image] =>[orig_patent_app_number] => 09881654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6525601 [patent_doc_number] => 20020192639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'HCV antigen/antibody combination assay' [patent_app_type] => new [patent_app_number] => 09/881239 [patent_app_country] => US [patent_app_date] => 2001-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 20738 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192639.pdf [firstpage_image] =>[orig_patent_app_number] => 09881239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6715782 [patent_doc_number] => 20030027130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Novel 3\' terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof' [patent_app_type] => new [patent_app_number] => 09/880508 [patent_app_country] => US [patent_app_date] => 2001-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21784 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027130.pdf [firstpage_image] =>[orig_patent_app_number] => 09880508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6611806 [patent_doc_number] => 20020064533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-30 [patent_title] => 'HBV core antigen particles with multiple immunogenic components attached via peptide ligands' [patent_app_type] => new [patent_app_number] => 09/873459 [patent_app_country] => US [patent_app_date] => 2001-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10081 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20020064533.pdf [firstpage_image] =>[orig_patent_app_number] => 09873459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6612424 [patent_doc_number] => 20020015944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Herpes simplex virus 1 UL 13 gene product: methods and compositions' [patent_app_type] => new [patent_app_number] => 09/870931 [patent_app_country] => US [patent_app_date] => 2001-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5492 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20020015944.pdf [firstpage_image] =>[orig_patent_app_number] => 09870931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 990677 [patent_doc_number] => 06919203 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-19 [patent_title] => 'Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus' [patent_app_type] => utility [patent_app_number] => 09/863054 [patent_app_country] => US [patent_app_date] => 2001-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 13747 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/919/06919203.pdf [firstpage_image] =>[orig_patent_app_number] => 09863054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7092407 [patent_doc_number] => 20010033845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-25 [patent_title] => 'Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence' [patent_app_type] => new [patent_app_number] => 09/845156 [patent_app_country] => US [patent_app_date] => 2001-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5749 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20010033845.pdf [firstpage_image] =>[orig_patent_app_number] => 09845156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1280664 [patent_doc_number] => 06642052 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-04 [patent_title] => 'Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease' [patent_app_type] => B2 [patent_app_number] => 09/843949 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 13428 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642052.pdf [firstpage_image] =>[orig_patent_app_number] => 09843949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1439348 [patent_doc_number] => 06495135 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-17 [patent_title] => 'Immortalized human keratinocyte cell line' [patent_app_type] => B2 [patent_app_number] => 09/844194 [patent_app_country] => US [patent_app_date] => 2001-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 15035 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495135.pdf [firstpage_image] =>[orig_patent_app_number] => 09844194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6896148 [patent_doc_number] => 20010026938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-04 [patent_title] => 'Adenovirus mutants with deleted protease gene, complementing cell lines, and corresponding vectors for gene transfer and positive selection of recombinant adenoviral vectors' [patent_app_type] => new [patent_app_number] => 09/820824 [patent_app_country] => US [patent_app_date] => 2001-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8941 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20010026938.pdf [firstpage_image] =>[orig_patent_app_number] => 09820824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1179422 [patent_doc_number] => 06740486 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-25 [patent_title] => 'Nucleic acid and polypeptide p10 of a Borna Disease virus (BDV) and their use for diagnostic and immunization purposes' [patent_app_type] => B1 [patent_app_number] => 09/763509 [patent_app_country] => US [patent_app_date] => 2001-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24391 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/740/06740486.pdf [firstpage_image] =>[orig_patent_app_number] => 09763509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342547 [patent_doc_number] => 06586412 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-01 [patent_title] => 'Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies' [patent_app_type] => B2 [patent_app_number] => 09/784982 [patent_app_country] => US [patent_app_date] => 2001-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5719 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586412.pdf [firstpage_image] =>[orig_patent_app_number] => 09784982 [rel_patent_id] =>[rel_patent_doc_number] =>)